Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Daniel Puleston has been awarded a four year Sir Henry Wellcome Postdoctoral Fellowship. The fellowship is designed to help promising early stage researchers launch an independent research career, and will support Daniel as he investigates the link between cellular metabolism and immunity.

Daniel will work with Prof Erika Pearce at the Max Planck Institute for Immunology, Germany, to examine how specific cellular metabolites support T cells in their ability to rapidly multiply in response to pathogens. Ultimately, Daniel hopes his studies will reveal vital signalling pathways that can be targeted to manipulate the immune response in diseases such as autoimmunity and cancer.

The project will also involve close collaboration with Kennedy investigators Prof Katja Simon and Prof Fiona Powrie, as well as Dr Alfredo Castello (Oxford) and Prof Doreen Cantrell (Dundee).

Speaking of his fellowship, Daniel said “I am incredibly grateful to receive a Sir Henry Wellcome Fellowship from the Wellcome Trust. This fellowship is unique in that it allows me to carry out my postdoctoral work at two world-class centres, the Kennedy Institute at Oxford and the Max Planck Institute for Immunology in Freiburg. The research performed in both locations will hopefully expand our knowledge on the role cellular metabolism plays in the immune response and how metabolic pathways can be targeted to modulate the immune system."

Daniel recently completed his DPhil with Prof Katja Simon. His work showed a cellular ‘cleanup’ process called autophagy is needed to establish long-term immunity after vaccination. He also found drugs that boost autophagy overcome the weak responses to vaccination that are associated with ageing.

Similar stories

Novo Nordisk Postdoctoral Research Fellowship awarded to Inhye Park

Inhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.

Researchers from the Kennedy Institute awarded MRC funding

Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.

EPSRC funds research to avert an antibiotics apocalypse

Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.

Major ERC funding awarded to Professor Michael Dustin

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Oxford University has today been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.